Updated information and services can be found at: The identification of a new murine pathogen, Helicobacter hepaticus, and its association with chronic active hepatitis and liver tumors prompted an evaluation of the prevalence of H. hepaticus in commercially available mice. Of the 28 different strains or stocks, totaling 160 mice from four major commercial vendors, cultured for H. hepaticus, 100% of mice from two outbred strains from one vendor were infected with H. hepaticus, whereas 9 of 13 inbred mouse strains from another vendor were infected. This high prevalence of H. hepaticus established a need for a rapid and reproducible, noninvasive assay for the screening of colony-maintained mice being used for biomedical research. The culturing of fecal material by using 0.45-m-pore-size filtration for H. hepaticus consistently yielded reproducible results but required extended periods of time (1 to 3 weeks) to obtain a definitive answer. Although it is rapid, the use of a direct PCR-based detection assay with fecal specimens is restricted by inhibitory agents. To circumvent these inhibitory agents and to augment our H. hepaticus culture technique, we have developed a novel PCR system in which the bacteria are isolated from fecal material in the presence of polyvinylpyropyrollidone and lysed by treatment with Chelex 100. The PCR is performed with Tth polymerase supplemented with a polymerase enhancer. By this PCR method, 24 H. hepaticus culture-positive and 30 H. hepaticus culture-negative fecal samples were correctly identified. Moreover, two samples which were PCR positive and culture negative initially were positive by both methods upon retesting of fresh material. Southern blot hybridizations and sequencing of PCR products showed them to be H. hepaticus specific. A comparison of results obtained under identical conditions indicated a 100-fold increase in sensitivity with Tth polymerase over Taq polymerase. This PCR method can be used as a noninvasive means of rapidly screening large numbers of colony mice for H. hepaticus.
The genus Helicobacter comprises a group of gram-negative, microaerophilic, spiral-to curve-shaped bacteria originally isolated from the stomachs of humans and other mammals (10) . The type species of the genus, H. pylori, causes chronic gastritis and peptic ulcer disease in humans and has more recently been linked to the development of gastric adenocarcinoma and gastric mucosa-associated lymphoma (5, 24) . Other Helicobacter spp., namely, H. felis, H. mustelae, H. acinonyx, and H. nemenstrinae, have been associated with various degrees of gastritis in their respective hosts (10) . Four Helicobacter spp. capable of colonizing the intestinal tract of rodents also have been recently characterized. H. muridarum, a colonizer of the cecum and ileum, also elicits a gastritis after colonization of gastric mucosa in older rodents (16) . ''Helicobacter rappini'' (''Flexispira rappini'') has been linked to abortion in sheep and diarrheal disease in humans (23) . H. bilis has recently been isolated from the bile, liver, cecum, and intestines of aged inbred mice (11) . H. hepaticus naturally colonizes the cecum and colon of mice and in certain strains can induce a persistent hepatitis (9) . In A/JCr mice, H. hepaticus is associated with hepatocellular carcinoma and hepatomas (27) .
Conventional microbiological culturing for the detection of specific infectious microorganisms requires the use of diverse media and growth conditions followed by identification of the pathogen by use of conventional diagnostic tests. In the case of H. hepaticus, it can take between 1 and 3 weeks to obtain sufficient growth of the organism on media for biochemical and phenotypic characterization of the bacterium. Furthermore, because of the fastidious nature of the organism, primary isolation is often compromised because of overgrowth by other fecal microorganisms, although we have alleviated these complications by means of selective filtration, which has proven effective in the culturing of other fastidious fecal organisms, particularly H. cinaedi (7, 12) . To ascertain the prevalence of H. hepaticus in a large number of mice from commercial sources, we used these conventional filtration techniques. Although they are specific, culture techniques are time-consuming. A specific and sensitive PCR-based assay on feces would facilitate the processing of a large number of samples.
PCR is a rapid and sensitive technique whereby a few copies of target DNA may be amplified to levels that can be detected by conventional gel electrophoresis or Southern blot hybridization. PCR has been used successfully to amplify H. hepaticus DNA from tissue isolates of infected mice (2, 8) . However, the presence of inhibiting factors, found in crude clinical samples of not only feces but also blood, urine, and saliva, often causes false-negative PCR results (14, 15, 18, 26) . These inhibitory agents found in body fluids include heparin in heparin-collected blood (21) ; chelating agents (17, 20) ; hemoglobin (13, 20) ; bilirubin, urobilogens, and bile salts in feces (28) ; and humic material (organic molecules resulting from the breakdown of animal or vegetable material) in environmental samples and in feces (4) .
To circumvent the effects of inhibitory agents and to augment the identification of H. hepaticus by culture, we have developed a novel PCR method which yields rapid, accurate, and reproducible results in identifying H. hepaticus in feces of mice.
MATERIALS AND METHODS

Animals.
Twenty-eight different strains or stocks, totaling 160 mice, from four major commercial vendors were cultured for H. hepaticus. Mice were shipped directly to our laboratory, euthanatized with CO 2 , and necropsied. The mice were shipped and housed together (up to four animals per cage) according to vendor and strain. No cohousing of identical strains from different vendors or of different strains from the same vendor occurred. In addition, different strains were not housed at the same time in our facilities and were housed for only 4 h prior to necropsy. Feces were collected from cages on the basis of these criteria.
Bacterial culture. Intestinal scrapings of the cecum and colon and a liver specimen aseptically collected from each mouse were cultured for H. hepaticus at 37ЊC on blood agar supplemented with TVP (trimethoprim, vancomycin, and polymyxin) (Remel Labs, Lenexa, Kans.) under microaerophilic conditions as previously described (9) .
In addition, freshly pooled fecal samples from each of 64 cages housing the specific strains of mice studied were homogenized in 1.0 ml of phosphatebuffered saline, and the slurry was gently passed through a 0.45-m syringe tip filter; this was followed by streaking onto TVP blood agar plates (Remel Labs). H. hepaticus was characterized by size (0.45-m-pore-size filtration), typical colony morphology, Gram stain reaction, and urease, catalase, and oxidase activities as described previously (9) . Cultures were held for 3 weeks to verify negative status.
Preparation of fecal sample for PCR. Approximately 100 mg of feces was diluted in 1 ml of 50 mM K 2 HPO 4 buffer (pH 8.0) containing 5 mg of polyvinylpyropyrolidone (PVPP) per ml. Because PVPP is insoluble, the solution was mixed before use. The samples were placed on ice for 1 h, with a vortexing of 15 s occurring once every 15 min. After the fourth vortexing, the sample was centrifuged for 2 min at 325 ϫ g, and the supernatant was removed and passed through a 0.8-m-pore-size filter (Schleider & Schuell, Keene, N.H.). The filtrate was then centrifuged for 30 min at 12,100 ϫ g, the supernatant was decanted, and the pellet was resuspended in 1 ml of sterile distilled water. Centrifugation at 12,100 ϫ g for 30 min was then repeated. The pellet, after air drying, was resuspended in 80 l of sterile water. Forty microliters of a 25% Chelex 100 resin-sterile distilled water suspension was added, and the solution incubated for 30 min at 60ЊC, vortexed for 15 s, boiled for 10 min, vortexed again for 15 s, and finally centrifuged for 3 min at 12,100 ϫ g. A 20-to 25-l sample was then taken from the supernatant for PCR.
PCR amplification of fecal DNA. The primer sequences chosen for PCR amplification recognized a region of the 16S rDNA specific for H. hepaticus (8, 9) . These two oligonucleotides, 5Ј GCA TTT GAA ACT GTT ACT CTG 3Ј (B38) and 5Ј CTG TTT TCA AGC TCC CC 3Ј (B39), produced an amplified product of 417 bp (Table 1) . Between 20 and 25 l of the fecal DNA preparation was added to a 100-l (final volume) reaction mixture containing 1ϫ Tth polymerase buffer (supplied by the manufacturer but supplemented with 1 M MgCl 2 to a final concentration of 3.0 mM), 0.5 M each of the two primers, 200 M each deoxynucleotide, and 200 g of bovine serum albumin per ml. Samples were heated at 94ЊC for 4 min, briefly centrifuged, and cooled to 61ЊC. At this time, 3.2 U of Tth polymerase (Boehringer Mannheim or Pharmacia) and 1.25 U of polymerase enhancer (Perfect Match, Stratagene, La Jolla, Calif.), followed by an overlay of 100 l of mineral oil were added. The following conditions were used for amplification: denaturation at 94ЊC for 1 min, annealing at 61ЊC for 2 1/4 min, and elongation at 72ЊC for 2 1/2 min. A total of 35 cycles were performed and were followed by an elongation step of 7 min at 72ЊC. A 10-to 15-l aliquot of the sample was then electrophoresed through a 6% Visigel separation matrix (Stratagene); this was followed by ethidium bromide staining and viewing by UV illumination. The specificity of the primers was tested under the above-mentioned conditions as well as with DNAs extracted from H. hepaticus, H. bilis, ''H.
rappini,'' H. mustelae, H. muridarum, H. felis, H. pylori, Campylobacter jejuni, Campylobacter coli, and Escherichia coli.
Comparison of Tth polymerase and Taq polymerase. Identical PCR conditions were set up with the same positive and negative fecal samples in order to compare the efficacies of Tth and Taq polymerases, with the only variation being the selection of the respective PCR buffers. Tth polymerase requires a slightly different buffer with a higher pH (8.9 as opposed to 8.4). However, both buffers were supplied by the same manufacturer (Boehringer Mannheim), and both were supplemented with MgCl 2 such that a final concentration of 3.0 mM was achieved.
Southern blot hybridization. For confirmation of the PCR-amplified DNA by Southern blot hybridization, 1/10 (10 l) of the PCR product was electrophoresed through a 2.0% NuSieve GTG agarose gel (FMC Bioproducts) and transferred onto a Hybond N nylon membrane as outlined by the manufacturer (Amersham, Arlington Heights, Ill.); this was followed by UV cross-linking. The fixed DNA was then subjected to hybridization with a PCR-generated probe prepared by using the H. hepaticus-specific 16S rDNA primers on phenol-chloroform-extracted DNA from the H. hepaticus type strain. The probe was labeled with horseradish peroxidase, hybridized overnight to the nylon membrane at 42ЊC, and exposed in the presence of luminal onto Hyperfilm-ECL as outlined by the manufacturer (Amersham).
Assay sensitivity. H. hepaticus DNA, purified by phenol-chloroform extraction, was quantitated, and known dilutions, ranging from 100 ng to 10 pg, were added to duplicate pairs of pooled supernatants isolated from the purification of fecal pellets from negative control mice as outlined above. For each dilution, one of the pairs was reacted with Tth polymerase and the other was reacted with Taq polymerase. After amplification, 10 l of each sample was taken, and the samples were compared by electrophoresis on a 6% Visigel separation matrix.
Conversely, in another experiment, samples from the lower dilutions were concentrated through a Microcon 100 apparatus (Amicon, Beverly, Mass.) and electrophoresed.
Comparison of fecal PCR with fecal culture. Fifty-six fecal samples from cages of mice suspected or known to be infected with H. hepaticus and from those suspected or known to be H. hepaticus free (on the basis of past experience with mice of a specific strain from a specific vendor) were collected and aliquoted such that half of the sample was subjected to PCR and the other half was subjected to culture. When a discrepancy occurred, a fresh culture was taken and both culture and PCR were repeated.
RESULTS
H. hepaticus in commercial mice. Two of the four commercial vendors had mice infected with H. hepaticus ( Table 2) . One vendor had 100% of the mice from two outbred strains infected, whereas the other vendor had mice from 9 of 13 inbred strains infected, with the overall incidence of H. hepaticus infection in individual mice being 52%. The remaining two commercial sources had mice free of H. hepaticus, but the majority of the mice from one of these sources were infected with H. bilis (11) .
An analysis of the sites sampled for H. hepaticus in infected mice indicates that both cecum (92%) and colon (76%) scrapings frequently yielded H. hepaticus-positive cultures, while the organism was never isolated from liver tissue (Table 3) .
When the culture results obtained from fecal filtration were compared with those from mucosal intestinal scrapings of the lower bowel for 64 mice, there was 100% concordance; 50 and 14 mice were H. hepaticus negative and positive, respectively, by both fecal filtration and intestinal scrapings.
Specificity of H. hepaticus 16S rRNA primers. Under our PCR conditions, a product of 417 bp was obtained with DNA purified from H. hepaticus. No cross-reaction was obtained with H. muridarum or ''H. rappini,'' the two closest species on the basis of 16S rRNA typing. Moreover, no reactions were observed with DNAs isolated from H. bilis, H. mustelae, H. felis, H. pylori, C. jejuni, C. coli, and E. coli.
Comparison of fecal PCR with fecal culture. Of the 56 samples tested by both methods, a direct correlation was obtained with 24 positive samples and 30 negative samples. The two remaining samples, with which a discrepancy was observed, were shown to correlate after a second culture and PCR were performed on fresh samples.
Comparison of Tth polymerase with Taq polymerase. As seen from the ethidium bromide-stained gel in Fig. 1a and its subsequent Southern blot hybridization in Fig. 1b , neither Tth nor Taq polymerase amplified H. hepaticus in the sample that was culture negative (lanes 1). Both enzymes amplified the positive control sample (lanes 7). The remaining five samples, which were culture positive, were also PCR positive with Tth polymerase (lanes 2 to 6). The corresponding Southern blot hybridization indicates that this band was also specific for H. hepaticus. With Taq polymerase, on the other hand, only two samples had positive PCR products after ethidium bromide staining alone, although the corresponding Southern blot did show positive signals with two additional samples (Fig. 1b,  lanes 3 and 5) , indicating that the quantity of PCR product amplified was less than the threshold detectable by conventional ethidium bromide staining techniques. No signal at all was apparent for the sample in Fig. 1, lanes 6 , which was known to be positive by both culture and PCR with Tth polymerase.
Identification of PCR product. In addition to the Southern hybridization described above, the 417-nucleotide product from one sample was fully sequenced. The sequence agreed exactly with that expected for H. hepaticus (9) .
Assay sensitivity. When known amounts of H. hepaticus DNA were added to pooled negative fecal supernatants, we were able to detect a PCR signal at amounts of between 0.5 and 0.1 ng (Fig. 2 ) in 10-l aliquots of PCR products from an amplification with Tth polymerase. When the entire sample was concentrated on a Microcon 100 apparatus, the sensitivity was increased about fivefold (data not shown). After amplification with Taq polymerase, the detectable levels were between 50 and 10 ng, which also increased fivefold after concentration with a Microcon 100 apparatus. This represents an increase in sensitivity of 100-fold with Tth polymerase versus Taq polymerase. 
DISCUSSION
To date, a chronic active hepatitis associated with H. hepaticus has been diagnosed in at least 15 mouse strains housed in 16 buildings at the Frederick Cancer Center premises (9) . Moreover, these hepatic lesions have been associated with a high incidence of hepatic tumors in A/JCr mice (27) . Furthermore, the hepatitis has been experimentally reproduced in A/J mice (27) . Our findings in this study also indicate that H. hepaticus-infected mice are prevalent in other commercial mouse colonies. Thus, the widespread existence of this new murine pathogen in mice being used in biomedical research is not surprising (8a). The epizootiology, although presently not completely elucidated, is most likely fecal-oral in nature given that the organism persistently colonizes the colon and cecum of infected mice. Interestingly, unlike our initial findings of positive H. hepaticus cultures in livers of A/JCr and SCID mice, livers of the mice in this study were negative for H. hepaticus by culture. This may be due to the young age of the animals surveyed or because the strains surveyed were less susceptible to liver colonization by H. hepaticus (9) . However, the high percentages of infected mice in numerous strains of mice indicate that the organism is an efficient colonizer of the lower intestine. Because of the high prevalence of this bacterium in mouse colonies and its apparent strong association with hepatic disease, a rapid, accurate, and noninvasive screening procedure to diagnose H. hepaticus in mouse colonies is important. The use of culture following selective filtration of feces through a 0.45-m-pore-size filter proved to be a highly specific indicator of H. hepaticus infection, and the results compared favorably with results obtained by the culturing of intestinal scrapings. The use of fecal filtration therefore provides a noninvasive means to diagnose H. hepaticus in infected colonies (8, 9) .
Since its introduction, PCR has proven to be a rapid method whereby microbial pathogens may be detected in clinical laboratories. However, direct PCR with fecal samples, as well as other body fluids, has been hampered by the presence of inhibitory substances. To circumvent these difficulties, we have developed a screening technique whereby reproducible PCR results may be obtained following a simple and quick purification protocol. In this technique, bacteria are released from the fecal material by treatment with PVPP, an agent used to isolate bacteria from soil. In our hands, the best results with the PVPP-treated samples were obtained at 4ЊC; the efficacy of the PCR decreased when the treatment was performed at higher temperatures, probably reflecting an increased release of inhibitors at higher temperatures.
As reported by other groups, the addition of a Chelex 100 treatment enhanced the final PCR (18, 28) . Also, it is important to note that in our assay there is an increased requirement for both Tth polymerase and polymerase enhancer over the amounts usually recommended by the manufacturer; i.e., 3.2 U of Tth polymerase and 1.25 U of polymerase enhancer are required, as opposed to the recommended 2.0 to 2.5 U and 1.0 U, respectively. These amounts were established as a result of tests performed on fecal extracts spiked with known amounts of H. hepaticus DNA, in which the concentrations of both Tth polymerase and polymerase enhancer were varied until optimal activity was achieved. The need for the increased levels of both reagents is probably a reflection of the presence of residual inhibitors present in the final preparation.
Tth polymerase has a decreased sensitivity to inhibitory components compared with Taq polymerase (3, 14, 19) , particularly in the presence of a single-stranded-DNA-binding protein such as Perfect Match (Stratagene). Others have attempted to use Tth polymerase with fecal isolates and found it to be more sensitive to inhibitors than Taq polymerase (28) . Indeed, in our initial trials we made the same observations when using the 10ϫ reaction buffer supplied by the manufacturer. However, in the 10ϫ buffer the concentration of MgCl 2 was 15 mM. By increasing the concentration of MgCl 2 to 30 mM in the 10ϫ buffer, a marked increase in sensitivity with no decrease in specificity of the PCR assay was achieved. The increased requirement for MgCl 2 may be due to the presence of chelators in the feces, which were added as preservatives to the animal's diet preparation. With increased MgCl 2 , we were able to detect positive signals in all of the five H. hepaticus-positive fecal samples, whereas with Taq polymerase only two of these samples could be detected as positive by PCR, although two more were rated as positive by Southern blotting (Fig. 1) . Southern blot hybridization also indicated that these bands were specific for H. hepaticus. A direct correlation was obtained with 24 positive and 30 negative fecal samples when H. hepaticus culture and PCR techniques were compared, and when fecal samples were spiked with known amounts of H. hepaticus DNA, a 100-fold increase in sensitivity with Tth polymerase versus Taq polymerase was observed.
In summary, we have developed a sensitive and accurate PCR assay for the detection of H. hepaticus in mouse feces. A single specific band from numerous fecal samples was obtained by using specific PCR primers. Following the completion of these studies, a publication by Battles et al. described a PCRbased H. hepaticus assay (2) . Although primers in similar locations were chosen, the particular sequences and PCR conditions differed. Using our optimized primers and PCR conditions, we did not see the nonspecific PCR products previously reported (2) . Under the PCR conditions described (11) . Moreover, because of the limited number of fecal samples (one positive and one negative) tested in the study by Battles et al. (2) , and from and our own experience with the unreliability of Taq polymerase (as indicated in Fig. 1 with our primers) , it is difficult to compare the efficacy of their assay with that of our assay for fecal isolates (2) . With the discovery of widespread H. hepaticus infection in commercially maintained mice as well as in mice being used in biomedical research, the use of both selective fecal filtration and PCR as described in this report will allow accurate diagnosis of the organism. This is a prerequisite for devising strategies to eradicate H. hepaticus from infected colonies as well as for implementing diagnostic surveillance protocols to maintain rederived colonies free of this new murine pathogen (9) . Furthermore, these techniques can be used to ascertain whether H. hepaticus has a wider host distribution.
